| Enzyme-responsive nanomaterials for controlled drug delivery Q Hu, PS Katti, Z Gu Nanoscale 6 (21), 12273-12286, 2014 | 539 | 2014 |
| IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts KE Hamilton, FK Noubissi, PS Katti, CM Hahn, SR Davey, ET Lundsmith, ... Carcinogenesis 34 (11), 2647-2654, 2013 | 82 | 2013 |
| Tissue-mimicking thermochromic phantom for characterization of HIFU devices and applications A Eranki, AS Mikhail, AH Negussie, PS Katti, BJ Wood, A Partanen International Journal of Hyperthermia, 2019 | 49 | 2019 |
| A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response J Wallis, P Katti, AM Martin, T Hills, LW Seymour, DP Shenton, ... European Journal of Pharmaceutical Sciences 152, 105456, 2020 | 16 | 2020 |
| Fringe benefits among us orthopedic residency programs vary considerably: a national survey RC Clement, E Olsson, P Katti, RJ Esther HSS Journal® 12 (2), 158-164, 2016 | 12 | 2016 |
| 5th International Symposium on Focused Ultrasound: North Bethesda, MD, USA. 28 August-1 September 2016 M Zaaroor, A Sinai, D Goldsher, A Eran, M Nassar, I Schlesinger, J Parker, ... Journal of Therapeutic Ultrasound 4, 1-113, 2016 | 2 | 2016 |
| Gas-stabilizing solid cavitation nuclei for systemic or transdermal ultrasound-enhanced drug and vaccine delivery and immunomodulation B Lyons, J Hettinga, J Balkaran, A Collins, M Maardalen, P Katti, ... The Journal of the Acoustical Society of America 150 (4_Supplement), A54-A54, 2021 | 1 | 2021 |
| Drug-device development: cancer immunotherapy with therapeutic, ultrasound-mediated delivery PS Katti University of Oxford (United Kingdom), 2020 | 1 | 2020 |
| Applications, mechanisms and real-time monitoring of enhanced drug transport by sustained inertial cavitation C Smith, C Mannaris, P Katti, C Paverd, C Coviello, R Carlisle, ... The Journal of the Acoustical Society of America 146 (4_Supplement), 2991-2991, 2019 | 1 | 2019 |
| Effect of radiofrequency ablation (RFA) combined with anti-CTLA-4 and anti-PD1 in a preclinical melanoma model. OL Franco-Mahecha, A Christou, M Mauda-Havakuk, P Katti, ... Journal of Clinical Oncology 37 (8_suppl), 143-143, 2019 | 1 | 2019 |
| Abstract No. 503 Effect of radiofrequency ablation (RFA) combined with checkpoint inhibition immunotherapy in a pre-clinical melanoma model OF Mahecha, A Christou, M Mauda-Havakuk, P Katti, W Pritchard, ... Journal of Vascular and Interventional Radiology 30 (3), S218, 2019 | | 2019 |
| Ultrasound-mediated targeted drug delivery in cancer patients–fact or fiction? P Lyon, P Katti RAD Magazine 44 (518), 12-14, 2018 | | 2018 |
| 5th International Symposium on Focused Ultrasound R Abounader, C Abraham, G Adema, P Agrawal, R Airan, D Aleman, ... | | 2016 |
| IMP1 mediates tumor size and dissemination into the blood in colorectal cancer cell xenografts. KE Hamilton, PS Katti, CM Hahn, SR Davey, ET Lundsmith, AD Rhim, ... Cancer Research 73 (8_Supplement), 253-253, 2013 | | 2013 |
| Passively Mapped Cavitation-Enhanced Oncological Drug Delivery using Sub-Micron Gas-Stabilizing Solid Particles CC Coussios, C Mannaris, PS Katti, C Paverd, A Martin, C Hill, J Wallis, ... | | |
